Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old
Clinical trial NCT02035696 · COMPLETED
Trial details
- NCT number
- NCT02035696
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-06-01
- Enrollment
- 671
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.